Allergy Therapeutics plc (AIM:AGY)

Allergy Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	12.79	12.92	14.85	20.52	40.27
Cash & Short-Term Investments	12.79	12.92	14.85	20.52	40.27
Cash Growth	-0.97%	-13.00%	-27.64%	-49.06%	8.96%
Accounts Receivable	2.85	2.86	2.37	2.69	2.96
Other Receivables	3.19	3.35	2.69	3.21	1.66
Receivables	6.03	6.21	5.06	5.91	4.62
Inventory	13.92	12.74	11.59	11.41	10.84
Prepaid Expenses	1.94	1.62	2.03	4.56	1.6
Other Current Assets	-	-	-	-	0.53
Total Current Assets	34.68	33.48	33.53	42.39	57.86
Property, Plant & Equipment	24.26	23.75	23.24	20.19	19.72
Goodwill	3.33	3.32	3.35	3.35	3.34
Other Intangible Assets	0.93	1.37	1.79	1.69	1.41
Long-Term Deferred Tax Assets	1.51	1.58	-	-	-
Other Long-Term Assets	2.84	2.91	4.87	5.33	5.76
Total Assets	67.54	66.41	66.77	72.95	88.09
Accounts Payable	4.49	4.01	4.09	4.28	2.9
Accrued Expenses	8.1	8.65	12.49	11.34	13.55
Current Portion of Long-Term Debt	0.41	0.6	0.65	0.95	0.96
Current Portion of Leases	1.48	1.52	1.16	1.32	0.79
Current Income Taxes Payable	0.91	1.43	-	-	-
Other Current Liabilities	11.81	2.59	0.18	0.16	0.03
Total Current Liabilities	27.19	18.8	18.57	18.05	18.23
Long-Term Debt	53.04	22.5	26.44	1.5	2.45
Long-Term Leases	5.17	6.37	7.75	6.76	6.97
Pension & Post-Retirement Benefits	8.59	8.61	7.92	8.32	11.29
Long-Term Deferred Tax Liabilities	0.07	0.06	0.45	0.41	0.41
Other Long-Term Liabilities	1.68	2.71	3.58	0.14	0.21
Total Liabilities	95.74	59.05	64.7	35.18	39.55
Common Stock	4.77	4.77	0.68	0.64	0.64
Additional Paid-In Capital	154.64	154.64	119.03	112.58	112.58
Retained Earnings	-235.23	-195.28	-161.87	-118.54	-107.4
Comprehensive Income & Other	47.63	43.23	44.23	43.09	42.72
Shareholders' Equity	-28.19	7.36	2.07	37.77	48.54
Total Liabilities & Equity	67.54	66.41	66.77	72.95	88.09
Total Debt	60.09	30.99	35.99	10.53	11.17
Net Cash (Debt)	-47.3	-18.07	-21.14	9.99	29.1
Net Cash Growth	-	-	-	-65.69%	17.42%
Net Cash Per Share	-0.01	-0.00	-0.03	0.02	0.04
Filing Date Shares Outstanding	4,766	4,766	679.1	644.1	641.77
Total Common Shares Outstanding	4,766	4,766	679.1	644.1	641.77
Working Capital	7.49	14.68	14.96	24.34	39.63
Book Value Per Share	-0.01	0.00	0.00	0.06	0.08
Tangible Book Value	-32.45	2.67	-3.07	32.73	43.78
Tangible Book Value Per Share	-0.01	0.00	-0.00	0.05	0.07
Land	3.14	3.01	3.05	3.08	3.09
Machinery	40.29	36.96	33.68	29.66	27.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.